Journal
EUROPEAN JOURNAL OF NEUROSCIENCE
Volume 26, Issue 10, Pages 2931-2939Publisher
BLACKWELL PUBLISHING
DOI: 10.1111/j.1460-9568.2007.05905.x
Keywords
BDNF; ERK; ginkgolides; PKA; RSK90
Categories
Funding
- NCCIH NIH HHS [R01AT001928-03A1] Funding Source: Medline
Ask authors/readers for more resources
Cyclic AMP response element-binding protein (CREB) plays important roles in neuronal plasticity and amyloid beta-peptide (A beta)-induced cognitive impairment in Alzheimer's disease (AD). Here we demonstrated that Ginkgo biloba extract, EGb 761, displayed the neuron protective effect by activating the CREB signaling pathway. Wild-type neuroblastoma cells cultured in a conditioned medium containing cell-secreted Alpha beta exhibited reduced levels of phosphorylated CREB (pCREB). Addition of EGb 761 (100 mu g/mL) or an anti-oligomer-specific antibody (A-11) to the conditioned medium could restore pCREB level. In a neuroblastoma cell line expressing Alpha beta, treatment with EGb 761 increased levels of pCREB and brain-derived neurotrophic factor. Furthermore, CREB phosphorylation induced by EGb 761 was blocked by inhibitors of several upstream signaling pathways of CREB, including protein kinase C, ERK, ribosomal S6 kinase(RSK)90 and nitric oxide pathway. Moreover, these inhibitors differentially blocked the effects of individual components of EGb 761, ginkgolide C, quercetin and bilobalide, which suggest diverse effects of the EGb 761 individual components. Actions of individual EGb 761 components provide further insights into direct mechanisms underlying the effect of EGb 761 on enhancing the cognitive performance of patients with AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available